Research Paper Volume 13, Issue 13 pp 17768—17788
Methylation silencing CDH23 is a poor prognostic marker in diffuse large B-cell lymphoma
Figure 1. The expression level, epigenetic regulation and prognostic value of CDH23 in DLBCL. (A) The expression level of CDH23 in DLBCL samples and paired normal samples determined by GEPIA. (B) The expression level of CDH23 in DLBCL samples and paired normal samples in GSE32018 dataset. (C) The expression level of CDH23 in DLBCL samples and paired normal samples in GSE56315 dataset. (D) The correlation of CDH23 expression and methylation value in DLBCL via LinkedOmics analysis. (E) The relationship between CDH23 expression and overall survival of DLBCL patients via GEPIA analysis. (F) The relationship between CDH23 expression and disease free survival of DLBCL patients via GEPIA analysis.